Preclinical Testing of MiRNA-193b-3p Mimic in Acute Myeloid Leukemias

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2023 Jun 13

PMID 37311946

Authors

Hasan Issa

Raj Bhayadia

Robert Winkler

Laura Elise Swart

Dirk Heckl

Jan-Henning Klusmann

Affiliations

Soon will be listed here.

Citing Articles

microRNA Profile of High-Grade B-Cell Lymphoma with 11q Aberration.

Zajdel M, Szafron L, Paziewska A, Rymkiewicz G, Dabrowska M, Bystydzienski Z Int J Mol Sci. 2025; 26(1.

PMID: 39796140 PMC: 11720131. DOI: 10.3390/ijms26010285.

Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia.

Prajapati S, Kumari N, Bhowmik D, Gupta R Ann Hematol. 2024; 103(11):4375-4400.

PMID: 39198271 DOI: 10.1007/s00277-024-05963-x.

miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.

Cheng Y, Fan Z, Liang C, Peng C, Li Y, Wang L Technol Cancer Res Treat. 2024; 23:15330338241248576.

PMID: 38693824 PMC: 11067685. DOI: 10.1177/15330338241248576.

MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications.

Hosseinpour-Soleimani F, Salmasi Z, Ghasemi Y, Tajbakhsh A, Savardashtaki A Heliyon. 2024; 10(7):e28167.

PMID: 38560206 PMC: 10979173. DOI: 10.1016/j.heliyon.2024.e28167.

MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization.

Jimbu L, Mesaros O, Joldes C, Neaga A, Zaharie L, Zdrenghea M Biomedicines. 2024; 12(1).

PMID: 38255226 PMC: 10813737. DOI: 10.3390/biomedicines12010121.

References

Zwaan C, Kolb E, Reinhardt D, Abrahamsson J, Adachi S, Aplenc R . Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2015; 33(27):2949-62. PMC: 4567700. DOI: 10.1200/JCO.2015.62.8289. View

Castaigne S, Pautas C, Terre C, Raffoux E, Bordessoule D, Bastie J . Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study. Lancet. 2012; 379(9825):1508-16. DOI: 10.1016/S0140-6736(12)60485-1. View

Klusmann J, Li Z, Bohmer K, Maroz A, Koch M, Emmrich S . miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev. 2010; 24(5):478-90. PMC: 2827843. DOI: 10.1101/gad.1856210. View

Bhayadia R, Krowiorz K, Haetscher N, Jammal R, Emmrich S, Obulkasim A . Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. J Clin Oncol. 2018; 36(10):1007-1016. DOI: 10.1200/JCO.2017.75.2204. View

Geest C, Coffer P . MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009; 86(2):237-50. DOI: 10.1189/jlb.0209097. View

Sun Y, Liu W, Liu T, Feng X, Yang N, Zhou H . Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015; 35(6):600-4. DOI: 10.3109/10799893.2015.1030412. View

Haetscher N, Feuermann Y, Wingert S, Rehage M, Thalheimer F, Weiser C . STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling. Nat Commun. 2015; 6:8928. PMC: 4674773. DOI: 10.1038/ncomms9928. View

Jyotsana N, Sharma A, Chaturvedi A, Budida R, Scherr M, Kuchenbauer F . Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo. Ann Hematol. 2019; 98(8):1905-1918. PMC: 7116733. DOI: 10.1007/s00277-019-03713-y. View

Pronk C, Rossi D, Mansson R, Attema J, Norddahl G, Chan C . Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell. 2008; 1(4):428-42. DOI: 10.1016/j.stem.2007.07.005. View

10.

Issa H, Swart L, Rasouli M, Ashtiani M, Nakjang S, Jyotsana N . Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia. Leukemia. 2023; 37(4):820-834. PMC: 10079536. DOI: 10.1038/s41375-023-01854-8. View

11.

Hong D, Kang Y, Borad M, Sachdev J, Ejadi S, Lim H . Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020; 122(11):1630-1637. PMC: 7251107. DOI: 10.1038/s41416-020-0802-1. View

12.

Li W, Wang Y, Liu R, Kasinski A, Shen H, Slack F . MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Front Cell Dev Biol. 2021; 9:640587. PMC: 7982597. DOI: 10.3389/fcell.2021.640587. View

13.

Bugarski D, Krstic A, Mojsilovic S, Vlaski M, Petakov M, Jovcic G . Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation. Exp Biol Med (Maywood). 2007; 232(1):156-63. View

14.

Lee Jr J, McCubrey J . The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia. 2002; 16(4):486-507. DOI: 10.1038/sj.leu.2402460. View